Rosatom Scientists Patent Tech for Separating Radium, Actinium, Thorium
ECONOMY & POLICY

Rosatom Scientists Patent Tech for Separating Radium, Actinium, Thorium

The technology developed by nuclear scientists has enabled the production of actinium-225 that has a wide application in atomedics. Specialists from the Department of Radionuclide Sources and Preparations at the Research Institute of Nuclear Reactors, State Scientific Centre (RIAR JSC belongs to Rosatom’s Scientific division) have obtained a patent for the technology of producing an actinium-225-based radioactive preparation.

Due to its unique properties, the isotope is deemed promising for use in the nuclear medicine and cancer therapy. The production technology ensures the product's high quality, as evidenced during all mandatory stages of monitoring of its specifications. Nowadays, alpha emitters, such as atinium-225, are regarded as one of the most promising areas in the atomedics. These isotopes are often referred to as "the future of cancer treatment". Rosatom and healthcare facilities are actively working in this field.

"Obtaining a patent is a significant milestone for the institute, one of the four global producers of actinium-225. This new development allowed the company, which ranks among the top three at Rosatom, to strengthen its position as an innovation leader. It is also significantly contributing to the advancements in the domestic science," said Andrey Shikunov, Deputy Director for Development and International Business at RIAR JSC.

The technology was developed by Dimitrovgrad scientists under an agreement with the Ministry of Industry and Trade of the Russian Federation. The Ministry granted the company a subsidy for scientific research and development following the competitive selection process.

The technology developed by nuclear scientists has enabled the production of actinium-225 that has a wide application in atomedics. Specialists from the Department of Radionuclide Sources and Preparations at the Research Institute of Nuclear Reactors, State Scientific Centre (RIAR JSC belongs to Rosatom’s Scientific division) have obtained a patent for the technology of producing an actinium-225-based radioactive preparation. Due to its unique properties, the isotope is deemed promising for use in the nuclear medicine and cancer therapy. The production technology ensures the product's high quality, as evidenced during all mandatory stages of monitoring of its specifications. Nowadays, alpha emitters, such as atinium-225, are regarded as one of the most promising areas in the atomedics. These isotopes are often referred to as the future of cancer treatment. Rosatom and healthcare facilities are actively working in this field. Obtaining a patent is a significant milestone for the institute, one of the four global producers of actinium-225. This new development allowed the company, which ranks among the top three at Rosatom, to strengthen its position as an innovation leader. It is also significantly contributing to the advancements in the domestic science, said Andrey Shikunov, Deputy Director for Development and International Business at RIAR JSC. The technology was developed by Dimitrovgrad scientists under an agreement with the Ministry of Industry and Trade of the Russian Federation. The Ministry granted the company a subsidy for scientific research and development following the competitive selection process.

Next Story
Infrastructure Transport

Versova–Dahisar Coastal Road Project to Impact 1,200 Trees

The Versova-Dahisar Coastal Road Project in Mumbai will affect over 1,200 trees, according to the Brihanmumbai Municipal Corporation (BMC). Of these, 990 trees will be replanted, while the remaining will be cut down due to construction requirements. The project, which forms a key extension of the on-going Mumbai Coastal Road corridor, aims to ease traffic congestion in the western suburbs and enhance north-south connectivity along the city’s coastline. The BMC has assured that replantation efforts will be carried out in designated areas to maintain ecological balance and offset the environm..

Next Story
Infrastructure Transport

New Entry-Exit Planned on Vadodara–Mumbai Expressway near Ankleshwar

The Vadodara–Mumbai Expressway is set to get a new entry and exit point near Ankleshwar, aimed at improving regional connectivity and reducing travel time for commuters in south Gujarat. The new interchange, proposed by the National Highways Authority of India (NHAI), will offer smoother access to nearby industrial and residential areas. The project forms part of the Bharatmala Pariyojana initiative, designed to strengthen India’s expressway network and boost economic corridors. Once operational, the new interchange is expected to enhance logistics efficiency by offering improved freight..

Next Story
Infrastructure Transport

DMRC and UITP Host Global Conference on Sustainable Urban Mobility

The Delhi Metro Rail Corporation (DMRC) and the International Association of Public Transport (UITP) jointly organized a global conference in New Delhi focusing on sustainable and inclusive urban mobility. The event brought together international experts, policymakers, and industry leaders to discuss strategies for enhancing public transport systems through innovation and green technologies. The conference addressed topics such as reducing carbon emissions, integrating multi-modal transport, improving accessibility, and adopting smart mobility solutions in rapidly growing cities. It also unde..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?